{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:02:30Z","timestamp":1775833350696,"version":"3.50.1"},"reference-count":107,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2013,3,25]],"date-time":"2013-03-25T00:00:00Z","timestamp":1364169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cancer stem cells or tumor-initiating cells (CSC\/TICs), which can undergo  self-renewal and differentiation, are thought to play critical roles in tumorigenesis, therapy resistance, tumor recurrence and metastasis. Tumor recurrence and chemoresistance are major causes of poor survival rates of ovarian cancer patients, which may be due in part to the existence of CSC\/TICs. Therefore, elucidating the molecular mechanisms responsible for the ovarian CSC\/TICs is required to develop a cure for this malignancy. Recent studies have indicated that the properties of CSC\/TICs can be regulated by microRNAs, genes and signaling pathways which also function in normal stem cells. Moreover, emerging evidence suggests that the tumor microenvironments surrounding CSC\/TICs are crucial for the maintenance of these cells. Similarly, efforts are now being made to unravel the mechanism involved in the regulation of ovarian CSC\/TICs, although much work is still needed. This review considers recent advances in identifying the genes and pathways involved in the regulation of ovarian CSC\/TICs. Furthermore, current approaches targeting ovarian CSC\/TICs are described. Targeting both CSC\/TICs and bulk tumor cells is suggested as a more effective approach to eliminating ovarian tumors. Better understanding of the regulation of ovarian CSC\/TICs might facilitate the development of improved therapeutic strategies for recurrent ovarian cancer.<\/jats:p>","DOI":"10.3390\/ijms14046624","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T04:34:12Z","timestamp":1364272452000},"page":"6624-6648","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Regulation of Ovarian Cancer Stem Cells or  Tumor-Initiating Cells"],"prefix":"10.3390","volume":"14","author":[{"given":"Mi","family":"Kwon","sequence":"first","affiliation":[{"name":"College of Pharmacy, Kyungpook National University, 80 Daehak-ro, Buk-gu,  Daegu 702-701, Korea"},{"name":"Research Institute of Pharmaceutical Sciences, College of Pharmacy,  Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu 702-701, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0896-718X","authenticated-orcid":false,"given":"Young","family":"Shin","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Pathology and Cancer Genomics, College of Pharmacy,  Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea"},{"name":"Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University,  1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea"},{"name":"Advanced Institutes of Convergence Technology, Suwon, Gyeonggi-do 443-270, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2013,3,25]]},"reference":[{"key":"ref_1","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA: A Cancer J. Clin"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"(2011). Integrated genomic analyses of ovarian carcinoma. Nature, 474, 609\u2013615.","DOI":"10.1038\/nature10166"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.201202014","article-title":"The evolving concept of cancer and metastasis stem cells","volume":"198","author":"Baccelli","year":"2012","journal-title":"J. Cell Biol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.2304","article-title":"The cancer stem cell: Premises, promises and challenges","volume":"17","author":"Clevers","year":"2011","journal-title":"Nat. Med"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer","volume":"29","author":"Singh","year":"2010","journal-title":"Oncogene"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1158\/0008-5472.CAN-04-3931","article-title":"Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer","volume":"65","author":"Bapat","year":"2005","journal-title":"Cancer Res"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Foster, R., Buckanovich, R.J., and Rueda, B.R. (2012). Ovarian cancer stem cells: Working towards the root of stemness. Cancer Lett.","DOI":"10.1016\/j.canlet.2012.10.023"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/1471-2407-12-359","article-title":"Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites","volume":"12","author":"Wintzell","year":"2012","journal-title":"BMC Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1073\/pnas.0603672103","article-title":"Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness","volume":"103","author":"Szotek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1158\/0008-5472.CAN-07-6341","article-title":"The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects","volume":"68","author":"Moserle","year":"2008","journal-title":"Cancer Res"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.bjc.6605626","article-title":"Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant","volume":"102","author":"Hu","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10585-012-9482-4","article-title":"CD44+\/CD24\u2212 ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival","volume":"29","author":"Meng","year":"2012","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/modpathol.2011.170","article-title":"CD133 expression associated with poor prognosis in ovarian cancer","volume":"25","author":"Zhang","year":"2012","journal-title":"Mod. Pathol"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e10277","DOI":"10.1371\/journal.pone.0010277","article-title":"Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers","volume":"5","author":"Deng","year":"2010","journal-title":"PLoS One"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/1535-7163.MCT-10-0563","article-title":"Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer","volume":"9","author":"Landen","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ajpath.2011.11.015","article-title":"ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome","volume":"180","author":"Wang","year":"2012","journal-title":"Am. J. Pathol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","article-title":"Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival","volume":"71","author":"Silva","year":"2011","journal-title":"Cancer Res"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.4161\/cc.20308","article-title":"Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype","volume":"11","author":"Ricci","year":"2012","journal-title":"Cell Cycle"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.4161\/cbt.22007","article-title":"Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate","volume":"13","author":"Wintzell","year":"2012","journal-title":"Cancer Biol. Ther"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","article-title":"Identification and characterization of ovarian cancer-initiating cells from primary human tumors","volume":"68","author":"Zhang","year":"2008","journal-title":"Cancer Res"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cc.8.1.7533","article-title":"Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance","volume":"8","author":"Alvero","year":"2009","journal-title":"Cell Cycle"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"18874","DOI":"10.1073\/pnas.1012667107","article-title":"Mullerian inhibiting substance preferentially inhibits stem\/progenitors in human ovarian cancer cell lines compared with chemotherapeutics","volume":"107","author":"Wei","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.yexmp.2011.06.005","article-title":"Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome","volume":"91","author":"Luo","year":"2011","journal-title":"Exp. Mol. Pathol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/onc.2010.35","article-title":"CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells","volume":"29","author":"Gao","year":"2010","journal-title":"Oncogene"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1007\/s00018-010-0420-9","article-title":"Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line","volume":"67","author":"Shi","year":"2010","journal-title":"Cell. Mol. Life Sci"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/onc.2008.374","article-title":"Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells","volume":"28","author":"Baba","year":"2009","journal-title":"Oncogene"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/stem.236","article-title":"CD133 expression defines a tumor initiating cell population in primary human ovarian cancer","volume":"27","author":"Curley","year":"2009","journal-title":"Stem Cells"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ijc.25967","article-title":"Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells","volume":"130","author":"Kryczek","year":"2012","journal-title":"Int. J. Cancer. Journal International du Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrclinonc.2010.196","article-title":"Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways","volume":"8","author":"Takebe","year":"2011","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1158\/1078-0432.CCR-09-2846","article-title":"Targeting Hedgehog--a cancer stem cell pathway","volume":"16","author":"Merchant","year":"2010","journal-title":"Clin. Cancer Res"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nature03319","article-title":"Wnt signalling in stem cells and cancer","volume":"434","author":"Reya","year":"2005","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1158\/0008-5472.CAN-05-3610","article-title":"Notch3 gene amplification in ovarian cancer","volume":"66","author":"Park","year":"2006","journal-title":"Cancer Res"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2353\/ajpath.2010.100316","article-title":"Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin","volume":"177","author":"Park","year":"2010","journal-title":"Am. J. Pathol"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2012.11.029","article-title":"Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer","volume":"128","author":"Ivan","year":"2012","journal-title":"Gynecol. Oncol"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"E2939","DOI":"10.1073\/pnas.1206400109","article-title":"Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy","volume":"109","author":"McAuliffe","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/carcin\/bgn230","article-title":"Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation","volume":"30","author":"Liao","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1349-7006.2006.00353.x","article-title":"Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: it\u2019s inhibition leads to growth suppression and apoptosis","volume":"98","author":"Chen","year":"2007","journal-title":"Cancer Sci"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1158\/1078-0432.CCR-08-1414","article-title":"Role of hedgehog signaling in ovarian cancer","volume":"14","author":"Bhattacharya","year":"2008","journal-title":"Clin. Cancer Res"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e28077","DOI":"10.1371\/journal.pone.0028077","article-title":"Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model","volume":"6","author":"McCann","year":"2011","journal-title":"PLoS One"},{"key":"ref_41","first-page":"797","article-title":"Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells","volume":"39","author":"Ray","year":"2011","journal-title":"Int. J. Oncol"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1172\/JCI59218","article-title":"Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells","volume":"122","author":"Mateo","year":"2012","journal-title":"J. Clin. Investig"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2119\/molmed.2012.00075","article-title":"Transformation of Epithelial Ovarian Cancer Stemlike Cells into Mesenchymal Lineage via EMT Results in Cellular Heterogeneity and Supports Tumor Engraftment","volume":"18","author":"Jiang","year":"2012","journal-title":"Mol. Med"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1038\/onc.2011.429","article-title":"Tissue transglutaminase links TGF-beta, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer","volume":"31","author":"Cao","year":"2012","journal-title":"Oncogene"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20110112","article-title":"Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment","volume":"437","author":"Barbolina","year":"2011","journal-title":"Biochem. J"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nature06835","article-title":"Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling","volume":"452","author":"Malanchi","year":"2008","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1073\/pnas.0900089106","article-title":"Dysregulated gene expression networks in human acute myelogenous leukemia stem cells","volume":"106","author":"Majeti","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-0897.2010.00914.x","article-title":"Regulation of inflammation by the NF-kappaB pathway in ovarian cancer stem cells","volume":"65","author":"Leizer","year":"2011","journal-title":"Am. J. Reprod. Immunol"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4161\/cc.23406","article-title":"TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence","volume":"12","author":"Chefetz","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc2946","article-title":"The genesis and evolution of high-grade serous ovarian cancer","volume":"10","author":"Bowtell","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/carcin\/bgr183","article-title":"Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells","volume":"32","author":"Motohara","year":"2011","journal-title":"Carcinogenesis"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Chau, W.K., Ip, C.K., Mak, A.S., Lai, H.C., and Wong, A.S. (2012). c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt\/beta-catenin-ATP-binding cassette G2 signaling. Oncogene.","DOI":"10.1038\/onc.2012.290"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1158\/0008-5472.CAN-07-5067","article-title":"Regulation of cancer cell survival, migration, and invasion by twist: AKT2 comes to interplay","volume":"68","author":"Cheng","year":"2008","journal-title":"Cancer Res"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1038\/onc.2010.111","article-title":"TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2\/214","volume":"29","author":"Yin","year":"2010","journal-title":"Oncogene"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/annonc\/mdl074","article-title":"Tumour stem cell-targeted treatment: elimination or differentiation","volume":"17","author":"Massard","year":"2006","journal-title":"Ann. Oncol.: Off. J. Euro. Soc. Med. Oncol. \/ESMO"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/onc.2012.33","article-title":"Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential","volume":"32","author":"Yin","year":"2012","journal-title":"Oncogene"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/carcin\/bgs243","article-title":"Functional study of risk loci of stem cell-associated gene lin-28B and associations with disease survival outcomes in epithelial ovarian cancer","volume":"33","author":"Lu","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Siu, M.K., Wong, E.S., Kong, D.S., Chan, H.Y., Jiang, L., Wong, O.G., Lam, E.W., Chan, K.K., Ngan, H.Y., and Le, X.F. (2012). Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers. Oncogene.","DOI":"10.1038\/onc.2012.363"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"9463","DOI":"10.1158\/0008-5472.CAN-10-2388","article-title":"Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/onc.2009.500","article-title":"Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer","volume":"29","author":"Peng","year":"2010","journal-title":"Oncogene"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"34970","DOI":"10.1074\/jbc.M112.374611","article-title":"MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53\/Nanog","volume":"287","author":"Xu","year":"2012","journal-title":"J. Biol. Chem"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","article-title":"A bivalent chromatin structure marks key developmental genes in embryonic stem cells","volume":"125","author":"Bernstein","year":"2006","journal-title":"Cell"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/ng1972","article-title":"A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing","volume":"39","author":"Ohm","year":"2007","journal-title":"Nat. Genet"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Chapman-Rothe, N., Curry, E., Zeller, C., Liber, D., Stronach, E., Gabra, H., Ghaem-Maghami, S., and Brown, R (2012). Chromatin H3K27me3\/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells. Oncogene.","DOI":"10.1038\/onc.2012.477"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cell.2009.02.005","article-title":"MicroRNAs and Cancer: Short RNAs Go a Long Way","volume":"136","author":"Ventura","year":"2009","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2007.10.054","article-title":"let-7 regulates self renewal and tumorigenicity of breast cancer cells","volume":"131","author":"Yu","year":"2007","journal-title":"Cell"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1038\/onc.2010.167","article-title":"Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells","volume":"29","author":"Yu","year":"2010","journal-title":"Oncogene"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cell.2009.07.011","article-title":"Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells","volume":"138","author":"Shimono","year":"2009","journal-title":"Cell"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1101\/gad.1640608","article-title":"The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2","volume":"22","author":"Park","year":"2008","journal-title":"Genes Dev"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"9125","DOI":"10.1158\/0008-5472.CAN-08-2629","article-title":"Targeting of the Bmi-1 oncogene\/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal","volume":"68","author":"Godlewski","year":"2008","journal-title":"Cancer Res"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1158\/0008-5472.CAN-09-0529","article-title":"MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.2284","article-title":"The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44","volume":"17","author":"Liu","year":"2011","journal-title":"Nature Med"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e6816","DOI":"10.1371\/journal.pone.0006816","article-title":"MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells","volume":"4","author":"Ji","year":"2009","journal-title":"PLoS One"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/1471-2407-8-266","article-title":"Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres","volume":"8","author":"Ji","year":"2008","journal-title":"BMC Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.22989","article-title":"Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells","volume":"50","author":"Ji","year":"2009","journal-title":"Hepatology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1742-4658.2012.08589.x","article-title":"MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells","volume":"279","author":"Cheng","year":"2012","journal-title":"FEBS J"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ygyno.2011.03.026","article-title":"MicroRNA-200a inhibits CD133\/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2","volume":"122","author":"Wu","year":"2011","journal-title":"Gynecol. Oncol"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Nam, E.J., Lee, M., Yim, G.W., Kim, J.H., Kim, S., Kim, S.W., and Kim, Y.T. (2012). MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line. BMC Med. Genomics, 5.","DOI":"10.1186\/1755-8794-5-18"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e18064","DOI":"10.1371\/journal.pone.0018064","article-title":"Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers","volume":"6","author":"Helland","year":"2011","journal-title":"PLoS One"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3390\/ijms12020983","article-title":"Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer","volume":"12","author":"Kwon","year":"2011","journal-title":"Int. J. Mol. Sci"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/ijc.26312","article-title":"The cancer stem cell niche-there goes the neighborhood?","volume":"129","author":"Cabarcas","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1471-2407-12-201","article-title":"The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells","volume":"12","author":"Liang","year":"2012","journal-title":"BMC Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1172\/JCI45273","article-title":"Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production","volume":"121","author":"McLean","year":"2011","journal-title":"J. Clin. Investig"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cc.23028","article-title":"Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment","volume":"12","author":"Ma","year":"2012","journal-title":"Cell Cycle"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"7294","DOI":"10.1158\/0008-5472.CAN-09-3982","article-title":"Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells","volume":"70","author":"Liao","year":"2010","journal-title":"Cancer Res"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/2159-8290.CD-12-0206","article-title":"MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer","volume":"2","author":"Mitra","year":"2012","journal-title":"Cancer Discov"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1078-0432.CCR-11-2188","article-title":"Stem cell pathways contribute to clinical chemoresistance in ovarian cancer","volume":"18","author":"Steg","year":"2012","journal-title":"Clin. Cancer Res.: An Off. J. Am. Assoc. Cancer Res"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrd2137","article-title":"Tumour-initiating cells: Challenges and opportunities for anticancer drug discovery","volume":"8","author":"Zhou","year":"2009","journal-title":"Nat. Rev. Drug Discov"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/1078-0432.CCR-12-1045","article-title":"Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer","volume":"19","author":"Ziebarth","year":"2012","journal-title":"Clin. Cancer Res"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1158\/1078-0432.CCR-09-2317","article-title":"Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides","volume":"15","author":"Slomiany","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1002\/cncr.26215","article-title":"Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin","volume":"117","author":"Casagrande","year":"2011","journal-title":"Cancer"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1158\/1535-7163.MCT-12-0002","article-title":"Growth inhibition of ovarian tumor-initiating cells by niclosamide","volume":"11","author":"Yo","year":"2012","journal-title":"Mol. Cancer Ther"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1158\/1535-7163.MCT-11-0023","article-title":"Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells","volume":"10","author":"Alvero","year":"2011","journal-title":"Mol. Cancer Ther"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ygyno.2012.07.115","article-title":"Metformin targets ovarian cancer stem cells in vitro and in vivo","volume":"127","author":"Shank","year":"2012","journal-title":"Gynecol. Oncol"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors of cancer stem cells by high-throughput screening","volume":"138","author":"Gupta","year":"2009","journal-title":"Cell"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1158\/1535-7163.MCT-11-0268","article-title":"A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells","volume":"10","author":"Visnyei","year":"2011","journal-title":"Mol. Cancer Ther"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1757-2215-5-30","article-title":"Identification of inhibitors of ovarian cancer stem-like cells by high-throughput screening","volume":"5","author":"Mezencev","year":"2012","journal-title":"J. Ovarian Res"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","article-title":"Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission","volume":"69","author":"Hirsch","year":"2009","journal-title":"Cancer Res"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1158\/0008-5472.CAN-10-3471","article-title":"Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types","volume":"71","author":"Iliopoulos","year":"2011","journal-title":"Cancer Res"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10549-010-0924-x","article-title":"The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells","volume":"126","author":"Menendez","year":"2011","journal-title":"Breast Cancer Res. Treat"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2008.04.008","article-title":"In vitro metformin anti-neoplastic activity in epithelial ovarian cancer","volume":"110","author":"Gotlieb","year":"2008","journal-title":"Gynecol. Oncol"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ygyno.2011.02.021","article-title":"Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins","volume":"121","author":"Yasmeen","year":"2011","journal-title":"Gynecol. Oncol"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1593\/neo.11148","article-title":"Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo","volume":"13","author":"Rattan","year":"2011","journal-title":"Neoplasia"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2011.12.425","article-title":"The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells","volume":"125","author":"Whitworth","year":"2012","journal-title":"Gynecol. Oncol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/4\/6624\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:45:45Z","timestamp":1760219145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/4\/6624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,25]]},"references-count":107,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4]]}},"alternative-id":["ijms14046624"],"URL":"https:\/\/doi.org\/10.3390\/ijms14046624","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,25]]}}}